INPP4A expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.10590003821187E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.79227999999032E-05 |
Normal-vs-Stage2 |
5.040900E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.782390E-02 |
Stage1-vs-Stage2 |
6.885800E-02 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.956000E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
8.089200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.04250000538309E-08 |
Normal-vs-AfricanAmerican |
1.649360E-01 |
Normal-vs-Asian |
8.660600E-03 |
Caucasian-vs-AfricanAmerican |
7.779400E-01 |
Caucasian-vs-Asian |
9.057400E-01 |
AfricanAmerican-vs-Asian |
4.479800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.590800E-04 |
Normal-vs-Female |
6.97679999994705E-07 |
Male-vs-Female |
9.581800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.864400E-03 |
Normal-vs-Extreme_Weight |
1.397010E-04 |
Normal-vs-Obese |
3.444000E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.187400E-01 |
Normal_Weight-vs-Obese |
5.731600E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
9.469200E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.508030E-01 |
Normal-vs-Age(41-60Yrs) |
7.413300E-04 |
Normal-vs-Age(61-80Yrs) |
8.26409999987732E-07 |
Normal-vs-Age(81-100Yrs) |
4.794600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.389800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.521200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.239200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.330800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.991200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.355200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
5.058400E-01 |
Normal-vs-Grade 3 |
2.618600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
9.275900E-02 |
Grade 2-vs-Grade 4 |
5.058400E-01 |
Grade 3-vs-Grade 4 |
2.618600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.87709999993824E-07 |
Normal-vs-N1 |
3.098200E-02 |
N0-vs-N1 |
8.073600E-01 |
|
|